News

We want to keep you abreast of the newest advancements in the healthtech sector and share when our companies make headlines.

Oct 28, 2020 The funding will advance R&D on the JAZBI™ bioresorbable implant system. The award also provides access to the NSW healthcare system resources and critical insights from NSW Health medical devices expert panel.
Oct 23, 2020 Cala Health announced that it had received FDA breakthrough device designation for its Cala Trio treatment for action tremors in people with Parkinson’s disease.
Oct 15, 2020 Inc.’s third annual Female Founders 100 celebrates the success stories and best business advice of the game-changing women of 2020.
Alessa’s Biolen implant is designed to deliver an anti-androgen drug to the target tissue in the prostate.
Sep 30, 2020 Along with funds announced a few months back, this brings the round’s total to $20.8 million.
Sep 18, 2020 The 900-participant study uses learnings from Apple’s Tueo Health acquisition and could inform the development of a digital biomarker for […]
Aug 31, 2020 Obsidio is a Rosenman Innovator company. From the press release. Obsidio, Inc., a pre-clinical stage medical materials developer, today announced […]
Aug 30, 2020 Deep Blue is a Rosenman Innovator company. From the press release. Deep Blue Medical Advances today announced it has received […]
Aug 25, 2020 Emme’s first offering aims to address unplanned pregnancy by improving pill adherence and management.